ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 955,97
0,52%
Dow Jones
38 225,66
0,00%
DAX
17 968,75
0,35%
Brent Oil
84,175
0,65%
Bitcoin
59 168,41
0,08%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Five Prime Therapeutics Inc (FPRX)

  7. Five Prime Therapeutics Inc (FPRX) Actualités

FPRX

Five Prime Therapeutics (FPRX)

Five Prime Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:FPRX
DateHeureSourceTitreSymboleSociété
15/02/202212h39Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:FPRXFive Prime Therapeutics Inc
22/04/202112h04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FPRXFive Prime Therapeutics Inc
20/04/202117h28TipRanksAmgen Completes The Acquisition Of Five Prime TherapeuticsNASDAQ:FPRXFive Prime Therapeutics Inc
20/04/202101h54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
16/04/202122h16Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:FPRXFive Prime Therapeutics Inc
16/04/202122h02Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:FPRXFive Prime Therapeutics Inc
16/04/202114h48Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:FPRXFive Prime Therapeutics Inc
16/04/202114h43Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:FPRXFive Prime Therapeutics Inc
16/04/202114h39Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:FPRXFive Prime Therapeutics Inc
16/04/202114h38Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FPRXFive Prime Therapeutics Inc
16/04/202114h25PR Newswire (US)Amgen Successfully Completes Acquisition Of Five Prime TherapeuticsNASDAQ:FPRXFive Prime Therapeutics Inc
18/03/202113h02Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:FPRXFive Prime Therapeutics Inc
09/03/202123h00Business WireFive Prime Cancels Fourth Quarter and Full-Year 2020 Financial Results Conference CallNASDAQ:FPRXFive Prime Therapeutics Inc
08/03/202123h02Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:FPRXFive Prime Therapeutics Inc
05/03/202122h20Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:FPRXFive Prime Therapeutics Inc
05/03/202109h57TipRanksAmgen Inks $1.9B Deal To Buy Five Prime Therapeutics; Shares Pop 79%NASDAQ:FPRXFive Prime Therapeutics Inc
04/03/202121h34Dow Jones NewsFive Prime Therapeutics Shares Gain After Amgen DealNASDAQ:FPRXFive Prime Therapeutics Inc
04/03/202115h20Dow Jones NewsAmgen to Acquire Five Prime Therapeutics for $1.9 Billion in CashNASDAQ:FPRXFive Prime Therapeutics Inc
04/03/202114h30PR Newswire (US)Amgen To Acquire Five Prime Therapeutics For $1.9 Billion in CashNASDAQ:FPRXFive Prime Therapeutics Inc
02/03/202122h05Business WireFive Prime Therapeutics Announces Timing of Its Fourth Quarter 2020 and Full Year Results Conference CallNASDAQ:FPRXFive Prime Therapeutics Inc
26/02/202123h00Business WireFive Prime Therapeutics to Participate in the Cowen 41st Annual Health Care ConferenceNASDAQ:FPRXFive Prime Therapeutics Inc
23/02/202100h00Business WireFive Prime Therapeutics to Participate in the SVB Leerink 10th Annual Global Healthcare ConferenceNASDAQ:FPRXFive Prime Therapeutics Inc
16/02/202122h47Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:FPRXFive Prime Therapeutics Inc
05/02/202115h25Business WireFive Prime Therapeutics to Participate in Guggenheim Healthcare Talks 2021: Oncology DayNASDAQ:FPRXFive Prime Therapeutics Inc
15/01/202112h55Business WirePhase 2 FIGHT Trial Results Presented at ASCO GI Validate Importance of FGFR2b Overexpression & Reinforce Potential of Bemari...NASDAQ:FPRXFive Prime Therapeutics Inc
09/12/202023h00Business WireFive Prime to Present Phase 2 FIGHT Trial Results of Bemarituzumab at American Society of Clinical Oncology (ASCO) Gastrointe...NASDAQ:FPRXFive Prime Therapeutics Inc
17/11/202023h00Business WireFive Prime Announces Closing of Upsized Public Offering of Common StockNASDAQ:FPRXFive Prime Therapeutics Inc
13/11/202023h28Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:FPRXFive Prime Therapeutics Inc
13/11/202004h00Business WireFive Prime Announces Pricing of Upsized Public Offering of Common StockNASDAQ:FPRXFive Prime Therapeutics Inc
12/11/202012h11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:FPRXFive Prime Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:FPRX

Dernières Valeurs Consultées

EU
ORA
Orange
FTSE
UKX
FTSE 100
EU
HO
Thales
EU
VIV
Vivendi
NYSE
KO
Coca Cola
EU
PX4
SBF 120
EU
SGO
Cie de SaintGobain
EU
DG
Vinci
EU
AI
Air Liquide
EU
EN
Bouygues
EU
CS
Axa
NASDAQ
NVDA
NVIDIA
COIN
ETHUSD
Ethereum
EU
MC
Lvmh Moet Hennessy Louis...
SPI
SP500
S&P 500
EU
VK
Vallourec
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés